Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

NCT07044336 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
Malignant Solid Tumour

Interventions

DRUG: Puxitatug Samrotecan
DRUG: Doxorubicin
DRUG: Paclitaxel

Sponsor

AstraZeneca